Figure: (a) MS peaks of 9 MPE probes without extension; (b) target site peaks of the MPE probes extended to non-SARS-CoV-2 variants; (c) target site peaks of the MPE probes extended to SARS-CoV-2
S gene mutation plasmid 1 (containing the HV69-70del,
K417N,
E484K,
N501Y,
D614G, and
P681H mutations); (d) target site peaks of the MPE probes extended to SARS-CoV-2
S gene mutation plasmid 2 (containing the
L452R,
E484Q, and
P681R mutations).
Abstract: Against AY.1 pseudoviruses, the
L452R and
K417N substitutions accounted for the loss of neutralization by four antibodies and one antibody, respectively, whereas one antibody lost potency that could not be fully accounted for by a single
RBD substitution.
Abstract: The
spike proteins of B.1.617.1, B.1.617.2, and AY.1 variants have several substitutions in the
receptor binding domain (
RBD), including
L452R+
E484Q,
L452R+
T478K, and
K417N+
L452R+
T478K, respectively, that could potentially reduce effectiveness of therapeutic antib